Tinefcon

  • Tinefcon 1
  • Tinefcon 2
Product Description

A patented & clinically proven product for management of psoriasis, backed up with years of extensive R&D and clinical trials1. Tinefcon is the WORLD’s first ORAL TNF- Alpha down regulator
2. Tinefcon presents the only holistic approach for the management of psoriasis in the market today
3. Efficacy comparable to Biologics & other systemically administered drugs
4. Proven clinical Efficacy & Safety profile
5. Globally Patent Protected ( 3 Patents for inflammatory disorders)6. 11 Publications in International journals

Read more Show less

Invex Health

  • IN
  • 2022
    On CPHI since
  • 4
    Certificates
  • 25 - 49
    Employees
Company types
Distributor/Import Export
Pharmaceutical company
Primary activities
Cosmeceuticals
Finished Formulation products Distributor/Buyer
Nutraceuticals
OTC
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    A patented & clinically proven product for management of psoriasis, backed up with years of extensive R&D and clinical trials.
  • Selling Points
    Brand Name; Packaging; Product Features; Product Performance; Plant Approvals: USFDA Registered, EU-GMP Approved, UAE Approved, FSSAI & more
    Launching soon in: USA, Canada, Singapore, Malaysia, Indonesia, Philippines, Vietnam & more.


    Under Registration in 15+ countries including Morocco, Sri Lanka, Egypt, Myanmar, Nepal, South Africa & more. 


    Already selling in India through ethical marketing & online route.
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

Invex Health

  • IN
  • 2022
    On CPHI since
  • 4
    Certificates
  • 25 - 49
    Employees
Company types
Distributor/Import Export
Pharmaceutical company
Primary activities
Cosmeceuticals
Finished Formulation products Distributor/Buyer
Nutraceuticals
OTC
Pharmaceutical Company (generic finished products)
View company profile

More Products from Invex Health (6)

  • Biosimilars

    Product Biosimilars

    Products: Trastuzumab Bevacizumab Rituximab Adalimumab Etanercept Tenecteplase Plant Approval: EUGMP, WHO GMP, Philippines FDA & TMMDA
  • Blood Products

    Product Blood Products

    Products: Human Albumin IVIG Dried Factor VIII Fraction Erythropoietin Darbepoetin alfa Injection Filgrastim Human Anti-D Immunoglobulin Plant Approval: WHOGMP, Kenya, Ethiopia
  • Peg-asparaginase & other oncology products

    Product Peg-asparaginase & other oncology products

    • Vandetanib tablets • L - Asparaginase injection • Peg - Asparaginase injection • Thiotepa injection • Melphalan injection • Paclitaxel Albumin bound nanoparticle injection • Plerixafor injection and more...
  • Bevacizumab & other Biosimilars

    Product Bevacizumab & other Biosimilars

    • Trastuzumab • Rituximab • Adalimumab • Etanercept • Tenecteplase & More
  • Human albumin & other Blood products

    Product Human albumin & other Blood products

    • Human Albumin IVIG • Dried Factor VIII Fraction • Erythropoietin • Darbepoetin alfa Injection • Filgrastim • Human Anti-D Immunoglobulin 
  • Cardio-Diabetics

    Product Cardio-Diabetics

    • Rifaximin tablets • Rivaroxaban tablets • Apixaban tablets and more.

Invex Health resources (4)

  • Product list (ROW market)

    Brochure Product list (ROW market)

    These are the products available for ROW markets with dossier status.
  • Product list - Stringent Regulated Markets

    Brochure Product list - Stringent Regulated Markets

    These are the products available for stringent regulated markets with Dossier status.
  • Special Product Range (Blood products & Biosimilars)

    Brochure Special Product Range (Blood products & Biosimilars)

    Available only for special import opportunities and selected ROW market registration
  • Invex Health e-brochure

    Brochure Invex Health e-brochure

    Invex Health is a global healthcare company offering a portfolio of 600+ products across Pharmaceuticals, Nutraceuticals, Dermo-cosmetics, and Medical Devices. We serve markets in SEA, LATAM, CIS, North America, and Africa backed by CMO plant approvals from top regulatory bodies like EU-GMP, PIC/S, UK-MHRA, WHO-GMP, T-FDA, NAFDAC, ANVISA, INVIMA, and more.
    We cover key therapeutic areas like Oncology, Biosimilars, Cardiovascular, Anti-diabetics, Dermatology, and Neurology & more.

    Our Services include: 
    Product RegistrationTender ParticipationTechnology TransferClinical Trial Supply